Home Business & Finance Bath & Body Works Surges on Stock Recommendation; Klarna...
Business & Finance

Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance | Stock Movers

Key Points

On this episode of Stock Movers: - Shares of Klarna (KLAR) plunged in premarket trading after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. The company cited foreign exchange pressures and volumes in Germany, even as it reported a profit beat for the second straight quarter. - Shares of Amylyx Pharmaceuticals (AMLX) extended its rally in the early session to as much as 54%, after the drug developer said a late-stage trial of...

On this episode of Stock Movers: - Shares of Klarna (KLAR) plunged in premarket trading after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. The company cited foreign exchange pressures and volumes in Germany, even as it reported a profit beat for the second straight quarter. - Shares of Amylyx Pharmaceuticals (AMLX) extended its rally in the early session to as much as 54%, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience low blood sugar levels following bariatric surgery. - Shares of Bath & Body Works (BBWI) surged ahead of the opening bell after Citi raised its recommendation on the stock to buy from neutral. Analyst Paul Lejuez cited a favorable risk/reward outlook in his note. The company is slated to release earnings next week. (Source: Bloomberg)
Bath & Body Works Surges on Stock Recommendation (ORG) Klarna Drops (PERSON) Stock Movers (ORG) Klarna (PERSON) KLAR (ORG) Germany (LOCATION) Amylyx Pharmaceuticals (ORG) Bath & Body Works (ORG) Citi (ORG) Paul Lejuez (PERSON) Bloomberg (PERSON)
Originally published by Bloomberg Markets Read original →